Medicine - General Internal Medicine

Search results

• Weekly: Intellia Therapeutics (NTLA: $30.84) decreases 0.6% on firm volume; -19c [0.6%]

  Cohen, F.

  2/12/23

  1 item of Media coverage

  Press/Media

• Weekly: Agilon Health (AGL: $11.28) down 6% in 2 weeks; -52c [4.4%] Vol Index 1.4 [1 is avg]

  Kornitzer, B.

  2/12/23

  1 item of Media coverage

  Press/Media

• Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs

  Jason Brett,

  1/12/23

  3 items of Media coverage

  Press/Media

• Novo Nordisk finds compounded Wegovy up to 33 per cent impure, sues Florida pharmacies

  Jason Brett,

  1/12/23

  1 item of Media coverage

  Press/Media

• Monthly: Agilon Health (AGL: $10.62) in bottom 1% performers of NYSE market in November 2023

  Kornitzer, B.

  1/12/23

  1 item of Media coverage

  Press/Media

• Monthly: Intellia Therapeutics (NTLA: $29.63) rises 24% on high volatility in November 2023

  Cohen, F.

  1/12/23

  1 item of Media coverage

  Press/Media

• 6 Important Blood Tests

  Weissman, M.

  1/12/23

  1 item of Media coverage

  Press/Media

• Monthly: ConocoPhillips (COP: $115.57) falls for a second consecutive month, a two-month fall of 3%

  Thomas, D.

  1/12/23

  1 item of Media coverage

  Press/Media

• Ozempic knock-offs contain an unsafe substance banned by the FDA

  Jason Brett,

  1/12/23

  1 item of Media coverage

  Press/Media

• Novo Nordisk Finds Compounded Wegovy up to 33% Impure, Sues Florida Pharmacies

  Jason Brett,

  30/11/23

  29 items of Media coverage

  Press/Media

• Novo Nordisk Files Lawsuits Over Impurities in Compounded Versions of GLP-1 Drugs

  Jason Brett,

  30/11/23

  1 item of Media coverage

  Press/Media

• Novo Nordisk Sues Florida Compounding Pharmacies Over Impurities In Products Claiming To Contain Wegovy Ingredient

  Jason Brett,

  30/11/23

  2 items of Media coverage

  Press/Media

• Novo Nordisk ramps up legal case against compounding pharmacies selling 'misbranded' semaglutide

  Jason Brett,

  30/11/23

  1 item of Media coverage

  Press/Media

• Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs

  Jason Brett,

  30/11/23

  5 items of Media coverage

  Press/Media

• Monthly: ConocoPhillips (COP: $115.57) falls for a second consecutive month, a two-month fall of 3%

  Thomas, D.

  30/11/23

  1 item of Media coverage

  Press/Media

• Ripon's early building progress and builders; Now & Then in Ripon.. Looking back with the Ripon Historical Society

  Thomas, D.

  30/11/23

  2 items of Media coverage

  Press/Media

• Novo Nordisk takes legal action over copycat Ozempic medication

  Jason Brett,

  30/11/23

  1 item of Media coverage

  Press/Media

• Ozempic Knock-Offs Contain Unsafe Substance, Novo Analysis Finds

  Jason Brett,

  30/11/23

  1 item of Media coverage

  Press/Media

• Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs

  Jason Brett,

  30/11/23

  1 item of Media coverage

  Press/Media

• Monthly: Intellia Therapeutics (NTLA: $29.63) rises 24% on high volatility in November 2023

  Cohen, F.

  30/11/23

  1 item of Media coverage

  Press/Media

• Ozempic Knock-Offs Contain an Unsafe Substance Banned by the FDA

  Jason Brett,

  30/11/23

  1 item of Media coverage

  Press/Media

• Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies

  Jason Brett,

  30/11/23

  2 items of Media coverage

  Press/Media

• Novo Nordisk takes additional legal actions to help protect US patients from potentially unsafe and ineffective compounded drugs claiming to contain semaglutide that are not FDA approved

  Jason Brett,

  30/11/23

  1 item of Media coverage

  Press/Media

• Novo Nordisk Claims Ozempic Knockoffs Aren’t Just Cheap — They’re Dangerous

  Jason Brett,

  30/11/23

  2 items of Media coverage

  Press/Media

• Novo Nordisk takes legal action over copycat weight loss medication

  Jason Brett,

  30/11/23

  23 items of Media coverage

  Press/Media